Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Benign neoplasm: Pituitary gland, craniopharyngeal duct based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 876 | 499 | 377 |
Unadjusted prevalence (%) | 0.34 | 0.34 | 0.33 |
Mean age at first event (years) | 49.76 | 47.07 | 53.31 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.05 | 3.46 [2.02, 5.91] | 6.0e-6 | 51 |
15 years | 0.02 | 3.49 [1.97, 6.20] | 2.0e-5 | 43 |
5 years | 0.00 | 4.03 [1.97, 8.24] | 1.3e-4 | 19 |
1 year | - | - | - | - |
Index endpoint: CD2_BENIGN_PITUITARY_CRANIPHAR – Benign neoplasm: Pituitary gland, craniopharyngeal duct
GWS hits: 1
before Benign neoplasm: Pituitary gland, craniopharyngeal duct
after Benign neoplasm: Pituitary gland, craniopharyngeal duct
Loading survival analyses plot
Loading survival analyses table